Stock comparison
Jeena Sikho Lifecare Limited
JSLL.BO$69.12BHealthcare Market cap, Sector
Krystal Biotech
KRYS$10.26BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
JSLL.BO 70 KRYS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.BO7wins
0winsKRYS
84B
D51
87A
B74
92A
B74
66C
D58
75B
D59
91A
C64
95A
C64
Side-by-side metrics
| Metric | JSLL.BO | KRYS |
|---|---|---|
| Market cap | Winner: $69.12B | $10.26B |
| P/E (TTM) | Winner: 33.2x | 39.9x |
| EV/EBIT | Winner: 24.1x | 52.9x |
| ROIC (TTM) | Winner: 39.15% | 13.85% |
| Gross margin | 88.58% | 92.79% Winner |
| Net margin | 27.68% | 53.92% Winner |
| Revenue CAGR 5y | 57.81% | - |
| EPS CAGR 5y | 86.67% | - |
| Debt / Equity | 0.3x | 0.0x Winner |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.BO leads on
- Market cap$69.12Bvs $10.26B+85%
- ROIC (TTM)39.15%vs 13.85%+65%
- EV/EBIT24.1xvs 52.9x+54%
- P/E (TTM)33.2xvs 39.9x+17%
KRYS leads on
- Debt / Equity0.0xvs 0.3x+99%
- Net margin53.92%vs 27.68%+49%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.